Intravenous Immunoglobulin (IVIG) Treatment Exerts Antioxidant and Neuropreservatory Effects in Preclinical Models of Alzheimer’s Disease
- 351 Downloads
Intravenous immunoglobulin (IVIG) has shown limited promise so far in human clinical studies on Alzheimer’s disease (AD), yet overwhelmingly positive preclinical work in animals and human brain cultures support the notion that the therapy remains potentially efficacious. Here, we elaborate on IVIG neuropreservation by demonstrating that IVIG protects human primary neurons against oxidative stress in vitro and that IVIG preserves antioxidant defense mechanisms in vivo. Based on these results, we propose the following translational impact: If the dosage and treatment conditions are adequately optimized, then IVIG treatment could play a significant role in preventing and/or delaying the progression of neurodegenerative diseases, such as AD. We suggest that IVIG warrants further investigation to fully exploit its potential as an anti-oxidant, neuroprotective and synapto-protecting agent.
KeywordsImmunoglobulin Alzheimer’s disease oxidative stress human neurons transgenic neuroprotection
We sincerely appreciate the grant support from the Alzheimer’s Association (Zenith award and IIRG; DKL), the NIH (DKL and SEC), Baxter Healthcare (DKL and SEC), and the St. Mary’s Foundation (SEC).
- 2.Lahiri DK, Long, JM, Maloney B, Greig NH. Lessons from a BACE1 inhibitor trial: Off-site but not off base. Alzheimers Dement. 2014. doi: 10.1016/j.jalz.2013.11.004.
- 6.Perez FP, Bose D, Maloney B, Nho K, Shah K, Lahiri DK. Late-onset Alzheimer’s disease (LOAD) heating up and foxed by several proteins: pathomolecular efects of the aging process. J Alzheimer Dis. 2014;40(1):1–17.Google Scholar
- 17.http://www.baxter.com/press_room/press_releases/2013/05_07_13_gap_study.html. Accessed 12/15/2013.
- 20.Counts S, Perez S, He B, Mufson E. Intravenous immunoglobulin reduces tau pathology and preserves neuroplastic gene expression in the 3xTg mouse model of Alzheimer’s disease. Current Alz Res. 2014; In press.Google Scholar
- 22.Bailey JA, Ray B, Lahiri DK. Intravenous immunoglobulin (IVIG) protects neuronal viability and synaptic markers in cultured degenerating primary hippocampal neurons. Societ Neurosci Abst. 2012;852.04.Google Scholar
- 24.Lahiri DK, Ray B. Intravenous Immunoglobulin (IVIG) treatment exerts a protective effect against oxidative insults in primary human neuronal mixed cultures. Curr Alzheimer Res. 2014; In press.Google Scholar